Peter J. Gray

Articles by Peter J. Gray


BIOLOGICAL AGENTS Genetic Vaccination: Can Plasmid DNA deliver its expectations?

VACCINES ARE EFFECTIVE AT protecting not only individuals but also communities. In the last fifty years, global immunisation programs have developed such strong “herd immunity” that some diseases, e.g. smallpox and polio, have been effectively eliminated. Currently, in terms of commercially available vaccines, the traditional methods of vaccine development are still leading the attack against… Read more »

By Malcolm R. Alderton , Peter J. Gray and David F. Proll In   Issue Volume 13 No. 2 Doi No https://doi-ds.org/doilink/04.2023-92278461/JMVH Vol 13 No 2

Enhancing Resistance to Sulphur Mustard Injury: Expression of Glutathione S-Transferase in Human Keratinocytes – Developing a Model to Explore Pre-Exposure Strategies

ABSTRACT THIS PAPER DESCRIBES the rationale for current work undertaken at the Chemical, Biological, Radiological and Nuclear Defence Centre (CERN DC) investigating the feasibility of pre-exposure approaches to counteracting the toxicity of the chemical warfare agent sulphur mustard (HD). HD is a vesicant that causes severe, slow-healing lesions in skin, lungs and eyes. The work… Read more »

By Sam Ross and Peter J. Gray In   Issue Volume 11 No. 2 Doi No https://doi-ds.org/doilink/03.2023-11464889/JMVH Vol 11 No 2

Genetic Vaccination: Can Plasmid DNA deliver its expectations?

Vaccines are effective at protecting not only individuals, but also communities. In the last fifty years, global immunisation programs have developed such strong “herd immunity” that some diseases, e.g. smallpox and polio, have been effectively eliminated. Currently, in terms of commercially available vaccines, the traditional methods of vaccine development are still leading the attack against… Read more »

By Malcolm R. Alderton , Peter J. Gray and David F. Prolf In   Issue Volume 10 No. 2 Doi No https://doi-ds.org/doilink/03.2023-95681947/JMVH Vol 10 No 2